During the past decade, Centro Urologico Profesor Bengio conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Urologico Profesor Bengio" are "Prostatic Neoplasms" (2 trials), "Urinary Bladder Neoplasms" (2 trials), "Abiraterone Acetate" (1 trials), "Androgens" (1 trials) and "Antineoplastic Agents" (1 trials). Many other conditions were trialed in "Centro Urologico Profesor Bengio" in a lesser frequency.

Most popular intervention types in "Centro Urologico Profesor Bengio" are "Drug" (7 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Erdafitinib" (2 trials), "Placebo" (2 trials), "Abemaciclib" (1 trials), "Abiraterone" (1 trials) and "Abiraterone acetate (AA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Urologico Profesor Bengio" are 4 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Urologico Profesor Bengio". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Urologico Profesor Bengio, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Urologico Profesor Bengio, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".